Economics of Genomic Medicine: Recent Insights
The business of genomic testing: a survey of early adopters.
James M. Crawford et al. Genetics in Medicine, July 10, 2014
CDC Commentary: Utility before business.
Teutsch S et al. Genetics in Medicine, July 10, 2014.
James M. Crawford et al. Genetics in Medicine, July 10, 2014
CDC Commentary: Utility before business.
Teutsch S et al. Genetics in Medicine, July 10, 2014.
CDC paper: Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.
Scott D. Grosse. Genetics in Medicine (2014)
The economic value of personalized medicine tests: what we know and what we need to know.
Kathryn A Phillips et al. Genetics in Medicine (2013)
Scott D. Grosse. Genetics in Medicine (2014)
The economic value of personalized medicine tests: what we know and what we need to know.
Kathryn A Phillips et al. Genetics in Medicine (2013)
Genomic sequencing: Assessing the health care system, policy, and big-data implications
Kathryn A. Phillips, et al. Health Affairs, July 2014
Kathryn A. Phillips, et al. Health Affairs, July 2014
Recent Publications
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T1, et al. Health Technol Assess. 2014 Sep;18(58):1-406. doi: 10.3310/hta18580.
Snowsill T1, et al. Health Technol Assess. 2014 Sep;18(58):1-406. doi: 10.3310/hta18580.
Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention
Patel V, et al. Pharm Pract (Granada) 2014 Jul;12(3):438
Patel V, et al. Pharm Pract (Granada) 2014 Jul;12(3):438
Cost-effectiveness of IL28Beta genotype-guided protease inhibitor triple therapy versus standard of care treatment in patients with hepatitis C genotypes 2 or 3 Infection
Bock JA, et al. Public Health Genomics 2014 Sep
Bock JA, et al. Public Health Genomics 2014 Sep
Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data
van der Ploeg CP, et al. J Cyst Fibros 2014 Sep
van der Ploeg CP, et al. J Cyst Fibros 2014 Sep
The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis
Beulen L, et al. Eur J Obstet Gynecol Reprod Biol 2014 Aug;182C:53-61
Beulen L, et al. Eur J Obstet Gynecol Reprod Biol 2014 Aug;182C:53-61
Genomic profile of breast cancer: cost–effectiveness analysis from the Spanish National Healthcare System perspective.
Miguel Ángel Seguí et al. Expert Review of Pharmacoeconomics & Outcomes Research September 12, 2014
Miguel Ángel Seguí et al. Expert Review of Pharmacoeconomics & Outcomes Research September 12, 2014
No hay comentarios:
Publicar un comentario